2022 Q1 Form 10-Q Financial Statement

#000155837022007630 Filed on May 06, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $15.57M $12.44M
YoY Change 25.16% 43.52%
Cost Of Revenue $7.232M $6.027M
YoY Change 19.99% -36.6%
Gross Profit $8.342M $6.416M
YoY Change 30.02% -867.46%
Gross Profit Margin 53.56% 51.56%
Selling, General & Admin $34.25M $44.45M
YoY Change -22.94% 298.39%
% of Gross Profit 410.6% 692.77%
Research & Development $23.62M $15.72M
YoY Change 50.31% 25.57%
% of Gross Profit 283.18% 244.95%
Depreciation & Amortization $839.0K $458.0K
YoY Change 83.19% 60.7%
% of Gross Profit 10.06% 7.14%
Operating Expenses $57.88M $60.16M
YoY Change -3.8% 154.15%
Operating Profit -$49.53M -$53.75M
YoY Change -7.84% 119.3%
Interest Expense $5.173M $638.0K
YoY Change 710.82% 12660.0%
% of Operating Profit
Other Income/Expense, Net -$100.0K -$631.0K
YoY Change -84.15% 2075.86%
Pretax Income -$44.46M -$666.0K
YoY Change 6575.68% -97.26%
Income Tax $17.00K $24.00K
% Of Pretax Income
Net Earnings -$44.48M -$690.0K
YoY Change 6345.94% -97.17%
Net Earnings / Revenue -285.58% -5.55%
Basic Earnings Per Share -$0.22 -$0.01
Diluted Earnings Per Share -$0.22 -$0.01
COMMON SHARES
Basic Shares Outstanding 199.0M 105.9M
Diluted Shares Outstanding 199.0M 105.9M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $359.9M $545.3M
YoY Change -34.0%
Cash & Equivalents $359.9M $18.85M
Short-Term Investments $526.4M
Other Short-Term Assets $52.98M $18.60M
YoY Change 184.84%
Inventory $48.35M $36.13M
Prepaid Expenses
Receivables $13.07M $5.237M
Other Receivables $0.00 $0.00
Total Short-Term Assets $474.3M $605.2M
YoY Change -21.63%
LONG-TERM ASSETS
Property, Plant & Equipment $22.77M $7.254M
YoY Change 213.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.371M $2.505M
YoY Change 194.25% 735.0%
Total Long-Term Assets $61.11M $42.29M
YoY Change 44.5% 13998.0%
TOTAL ASSETS
Total Short-Term Assets $474.3M $605.2M
Total Long-Term Assets $61.11M $42.29M
Total Assets $535.4M $647.5M
YoY Change -17.31% 215726.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.683M $5.268M
YoY Change -49.07%
Accrued Expenses $31.95M $37.60M
YoY Change -15.03% 18700.0%
Deferred Revenue $13.36M $9.548M
YoY Change 39.91%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.71M $52.37M
YoY Change -3.18% 17357.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $828.0K $2.055M
YoY Change -59.71%
Total Long-Term Liabilities $828.0K $2.055M
YoY Change -59.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.71M $52.37M
Total Long-Term Liabilities $828.0K $2.055M
Total Liabilities $122.8M $211.3M
YoY Change -41.91% 70338.33%
SHAREHOLDERS EQUITY
Retained Earnings -$471.7M -$395.5M
YoY Change 19.27%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $412.7M $436.2M
YoY Change
Total Liabilities & Shareholders Equity $535.4M $647.5M
YoY Change -17.31% 215726.0%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$44.48M -$690.0K
YoY Change 6345.94% -97.17%
Depreciation, Depletion And Amortization $839.0K $458.0K
YoY Change 83.19% 60.7%
Cash From Operating Activities -$54.23M -$63.43M
YoY Change -14.49% 222.46%
INVESTING ACTIVITIES
Capital Expenditures $4.506M $1.289M
YoY Change 249.57% 168.54%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$526.9M
YoY Change -100.0%
Cash From Investing Activities -$4.506M -$528.2M
YoY Change -99.15% 109941.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $4.366M
YoY Change -100.0%
Cash From Financing Activities 550.0K 550.3M
YoY Change -99.9% 357216.88%
NET CHANGE
Cash From Operating Activities -54.23M -63.43M
Cash From Investing Activities -4.506M -528.2M
Cash From Financing Activities 550.0K 550.3M
Net Change In Cash -58.19M -41.36M
YoY Change 40.71% 106.82%
FREE CASH FLOW
Cash From Operating Activities -$54.23M -$63.43M
Capital Expenditures $4.506M $1.289M
Free Cash Flow -$58.74M -$64.72M
YoY Change -9.23% 221.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001804176
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
199000258
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105916706
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Butterfly Network, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4618156
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
530 Old Whitfield Street
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Guilford
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06437
CY2022Q1 dei City Area Code
CityAreaCode
203
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
689-5650
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39292
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
359901000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
422841000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13071000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11936000
CY2022Q1 us-gaap Inventory Net
InventoryNet
48354000
CY2021Q4 us-gaap Inventory Net
InventoryNet
36243000
CY2022Q1 bfly Vendor Advances Current
VendorAdvancesCurrent
29424000
CY2021Q4 bfly Vendor Advances Current
VendorAdvancesCurrent
27500000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23556000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13384000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
474306000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
511904000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22767000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14703000
CY2022Q1 bfly Vendor Advances Non Current
VendorAdvancesNonCurrent
7452000
CY2021Q4 bfly Vendor Advances Non Current
VendorAdvancesNonCurrent
12782000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23524000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24083000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7371000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8493000
CY2022Q1 us-gaap Assets
Assets
535420000
CY2021Q4 us-gaap Assets
Assets
571965000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2683000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5798000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13359000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13071000
CY2022Q1 bfly Accrued Purchase Commitments Current
AccruedPurchaseCommitmentsCurrent
5743000
CY2021Q4 bfly Accrued Purchase Commitments Current
AccruedPurchaseCommitmentsCurrent
5329000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
28922000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
25631000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
50707000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49829000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6272000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5476000
CY2022Q1 bfly Warrant Liability
WarrantLiability
21066000
CY2021Q4 bfly Warrant Liability
WarrantLiability
26229000
CY2022Q1 bfly Accrued Purchase Commitments Non Current
AccruedPurchaseCommitmentsNonCurrent
13786000
CY2021Q4 bfly Accrued Purchase Commitments Non Current
AccruedPurchaseCommitmentsNonCurrent
14200000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30097000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27690000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
828000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
850000
CY2022Q1 us-gaap Liabilities
Liabilities
122756000
CY2021Q4 us-gaap Liabilities
Liabilities
124274000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
884336000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
874886000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-471692000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-427215000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
412664000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
447691000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
535420000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
571965000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15574000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12443000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
7232000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
6027000
CY2022Q1 us-gaap Gross Profit
GrossProfit
8342000
CY2021Q1 us-gaap Gross Profit
GrossProfit
6416000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23623000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15716000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15202000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9808000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19050000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34640000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
57875000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
60164000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-49533000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-53748000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
239000
CY2021Q1 us-gaap Interest Expense
InterestExpense
638000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5163000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-54112000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-631000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44460000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-666000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44477000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-690000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
199000258
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105916706
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-361931000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-690000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6313000
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
360937000
CY2021Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
49917000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
361287000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20330000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
436163000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
447691000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44477000
CY2022Q1 bfly Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
651000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-106000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8905000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
412664000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-44477000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-690000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
839000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
458000
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
0
CY2021Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
389000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8730000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
20298000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5163000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-54112000
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
40000
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
397000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1179000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-585000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12111000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10324000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5455000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6114000
CY2022Q1 bfly Increase Decrease In Vendor Advances
IncreaseDecreaseInVendorAdvances
-3406000
CY2021Q1 bfly Increase Decrease In Vendor Advances
IncreaseDecreaseInVendorAdvances
1744000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-3176000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11000000
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1084000
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2329000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
622000
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-306000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2606000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3593000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54234000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63427000
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
691908000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
165000000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4506000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1289000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4506000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-528197000
CY2022Q1 bfly Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
651000
CY2021Q1 bfly Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
6283000
CY2022Q1 bfly Proceeds From Equity Infusion From Business Combination Net
ProceedsFromEquityInfusionFromBusinessCombinationNet
0
CY2021Q1 bfly Proceeds From Equity Infusion From Business Combination Net
ProceedsFromEquityInfusionFromBusinessCombinationNet
548403000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4366000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-101000
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-52000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
550000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
550268000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-58190000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41356000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
426841000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60206000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
368651000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18850000
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, and accounts receivable. At March 31, 2022, substantially all of the Company’s cash and cash equivalents were invested in money market accounts at one financial institution. The Company also maintains balances in various operating accounts above federally insured limits. The Company has not experienced any significant losses on such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">One customer accounted for 14% and 15% of the Company’s accounts receivable as of March 31, 2022 and December 31, 2021, respectively. For the three months ended March 31, 2022 and 2021, no customer accounts for more than 10% of the total revenues.</p>
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The Company makes estimates and assumptions about future events that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates, judgments and assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company bases its estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed consolidated financial statements. There have been no material changes to the Company’s use of estimates as described in the audited consolidated financial statements as of December 31, 2021.</p>
CY2021Q1 bfly Business Combination Increase In Cash
BusinessCombinationIncreaseInCash
589500000
CY2021Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
11400000
CY2021Q1 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
30900000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
186500000
CY2021Q1 bfly Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Warrant Liability
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability
187300000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15574000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12443000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15574000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12443000
CY2022Q1 bfly Duration For Payment Terms
DurationForPaymentTerms
P30D
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
400000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
400000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4700000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3300000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22800000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.65
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.35
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
32158000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
19853000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
3583000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1122000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12613000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
15268000
CY2022Q1 us-gaap Inventory Net
InventoryNet
48354000
CY2021Q4 us-gaap Inventory Net
InventoryNet
36243000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28940000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20079000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6173000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5376000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22767000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14703000
CY2022Q1 bfly Accrued Property And Equipment
AccruedPropertyAndEquipment
2000000.0
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
359901000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18850000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
368651000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18850000
CY2021Q2 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
4000000.0
CY2022Q1 bfly Proceeds From Grant Received
ProceedsFromGrantReceived
4800000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5846000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12746000
CY2022Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
934000
CY2021Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1850000
CY2022Q1 bfly Deferred Grant Funding Current
DeferredGrantFundingCurrent
4750000
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
265000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
266000
CY2022Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1783000
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
2477000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4947000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2797000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1590000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1391000
CY2022Q1 bfly Accrued Inventory Obligation
AccruedInventoryObligation
1775000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7032000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4104000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
28922000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
25631000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1116000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1826000
CY2022Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
161000
CY2021Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-392000
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
183000
CY2021Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
248000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1094000
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1186000
CY2022Q1 bfly Percentage Of Increment In Of Shares Outstanding
PercentageOfIncrementInOfSharesOutstanding
0.04
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105916706
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8730000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20298000
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
44477000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44477000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
199000258
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
199000258
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
690000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-690000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105916706
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46952321
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46075623
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1200000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
600000

Files In Submission

Name View Source Status
0001558370-22-007630-index-headers.html Edgar Link pending
0001558370-22-007630-index.html Edgar Link pending
0001558370-22-007630.txt Edgar Link pending
0001558370-22-007630-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20220331.xsd Edgar Link pending
tmb-20220331x10q.htm Edgar Link pending
tmb-20220331x10q006.jpg Edgar Link pending
tmb-20220331x10q007.jpg Edgar Link pending
tmb-20220331x10q_htm.xml Edgar Link completed
tmb-20220331xex10d1.htm Edgar Link pending
tmb-20220331xex10d1001.jpg Edgar Link pending
tmb-20220331xex10d1002.jpg Edgar Link pending
tmb-20220331xex10d1003.jpg Edgar Link pending
tmb-20220331xex31d1.htm Edgar Link pending
tmb-20220331xex31d2.htm Edgar Link pending
tmb-20220331xex32.htm Edgar Link pending
tmb-20220331_cal.xml Edgar Link unprocessable
tmb-20220331_def.xml Edgar Link unprocessable
tmb-20220331_lab.xml Edgar Link unprocessable
tmb-20220331_pre.xml Edgar Link unprocessable